Boxed Warning
WARNING: RISK OF UTERINE RUPTURE, ABORTION, PREMATURE BIRTH, BIRTH EFECTS; SERIOUS CARDIOVASCULAR EVENTS; AND SERIOUS GASTROINTESTINAL EVENTS
Uterine Rupture, Abortion, Premature Birth, and Birth Defects
Administration of misoprostol, a component of diclofenac sodium and misoprostol delayed-release tablets, to pregnant women can cause Uterine rupture, abortion, premature birth, or birth defects. Uterine rupture has occurred when misoprostol was administered In pregnant women to Induce labor or an abortion [see
Warnings and Precautions (5.1) and
Use in Specific Populations (8.1)].
Diclofenac sodium and misoprostol delayed-release tablets are contraindicated in pregnancy [see Contraindications (4)] and not recommended in women of childbearing potential. Patients must be advised of the abortifacient property and warned not to give the drug lo others [see
Warnings and Precautions (5.1)]
If diclofenac sodium and misoprostol delayed-release tablets are prescribed, verify the pregnancy status of females of reproductive potential prior to initiation of treatment and advise them to use effective contraception during treatment [see
Use in Specific Populations (8.3)]
Cardiovascular Thrombotic Events
NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use [see Warnings and Precautions (5.2)].
Diclofenac sodium and misoprostol delayed-d release tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery [see
Contraindications (4) and
Warnings and Precautions (5.2)].
Gastrointestinal Bleeding Ulceration and Perforation
NSAIDs cause an Increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events [see Warnings and Precautions (5.3)].